PCAR
67
2
CFG
83
-4
COF
60
-5
MUR
42
3
ADM
68
3
PSA
55
4
BK
72
-2
KLAC
77
6
CB
57
-4
EQT
44
-3
AVY
55
2
NOV
67
2
ZTS
27
4
PFE
45
2
LB
29
11
DHI
58
10
AA
72
2
BAC
69
-2
DGX
37
-5
MKC
39
3
PCAR
67
2
CFG
83
-4
COF
60
-5
MUR
42
3
ADM
68
3
PSA
55
4
BK
72
-2
KLAC
77
6
CB
57
-4
EQT
44
-3
AVY
55
2
NOV
67
2
ZTS
27
4
PFE
45
2
LB
29
11
DHI
58
10
AA
72
2
BAC
69
-2
DGX
37
-5
MKC
39
3
Financhill
Back

Matinas BioPharma Holdings, Inc. Stock Predictions

Meet America's Newest $1B Unicorn

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
23

MTNB
Matinas BioPharma Holdings, Inc.

Last Price:
$0.64
Seasonality Move:
0.4%

7 Day Trial

ALL ACCESS PASS

$ 7

The Next Gold Rush

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at

Matinas BioPharma Holdings, Inc. Stock Forecast

  • Is Matinas BioPharma Holdings, Inc. Stock Undervalued?
    The current Matinas BioPharma Holdings, Inc. [MTNB] share price is $0.64. The Score for MTNB is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • MTNB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Matinas BioPharma Holdings, Inc. Stock Go Up Next Year?

Data Unavailable

Matinas BioPharma Holdings, Inc. Stock Rating

Data Unavailable

Matinas BioPharma Holdings, Inc. Stock Price History

Is MTNB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTNB is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
matinasbiopharma.com

52-Week Data

52-Week High:
3.09
52-Week Low:
0.47

Prediction Charts

Market Cap:
4.1M
Price in USD:
0.64
Volume:
24.5K
Beta:
1.85

Technical Analysis

SMA50:
0.92
SMA100:
1.37
SMA200:
1.09
52-Wk Change:
-3.06%

Stock Predictions

  • Is Matinas BioPharma Holdings, Inc. stock public?
    Yes, Matinas BioPharma Holdings, Inc. is a publicly traded company.
  • What is the Matinas BioPharma Holdings, Inc. stock quote today?
    The Matinas BioPharma Holdings, Inc. stock price is 0.64 USD today.
  • How to buy Matinas BioPharma Holdings, Inc. stock online?
    You can buy Matinas BioPharma Holdings, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-17 0.72 0.72 0.79 0.71
Dec-18 0.73 0.78 0.78 0.71
Dec-19 0.77 0.73 0.78 0.73
Dec-22 0.73 0.75 0.80 0.73
Dec-24 0.68 0.69 0.70 0.68
Dec-26 0.71 0.62 0.71 0.60
Dec-29 0.60 0.60 0.61 0.58
Dec-30 0.57 0.59 0.59 0.56
Dec-31 0.58 0.59 0.64 0.57
Jan-5 0.60 0.64 0.67 0.60
Jan-6 0.56 0.60 0.64 0.56
Jan-7 0.66 0.67 0.68 0.62
Jan-8 0.68 0.73 0.73 0.61
Jan-9 0.73 0.64 0.75 0.64

Matinas BioPharma Holdings, Inc. Earnings

Data Unavailable

Matinas BioPharma Holdings, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.50 per share, and a decrease next year of $0.00 per share.

* Matinas BioPharma Holdings, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.